
Egypt's Ministry of Health and Population has announced the first phase of the Vaccine and Biotechnology City is 100% complete, with infrastructure at approximately 90%. Dr. Hossam Abdel Ghaffar, spokesperson for the Ministry, stated that the city, covering 115,000 square meters with 32 buildings, aims to localize vaccine manufacturing, achieve self-sufficiency, and boost exports. The project includes three human vaccine factories, three veterinary vaccine factories, research laboratories, and a logistics complex. By 2030, the city targets an annual production capacity of 140 million human doses and 5.5 billion veterinary doses, increasing to 690 million human doses and 11 billion veterinary doses by 2040, potentially covering 16% of Africa's needs. Egypt plans to produce 50% of its vaccine needs locally by 2030, 75% by 2035, and achieve complete self-sufficiency by 2040, focusing on essential vaccines like influenza and polio. The VBC Academy will serve as a regional knowledge center for training and research, supporting Egypt's goal to become a leading regional hub for vaccine manufacturing and export to over 60 countries.
Free daily or weekly digest of the most important stories from across 10 countries. No spam, unsubscribe any time.
This summary was AI-generated from a story originally published by Egypt Today.